Weight Changes and hormonal contraceptives

March 19, 2024

People gain weight as they age regardless of contraceptive use because their body metabolism changes and therefore weight increases if they make no compensatory changes in nutrition and activity. Key events over the reproductive lifespan, including puberty, pregnancy, and menopause, can have significant effects on metabolism and weight. Early identification of weight gain allows for timely discussion about changes in nutrition, activity, or contraceptive method, write Megan Lawley, MD, MPH, and Carrie Cwiak, MD, MPH, in the new edition of Contraceptive Technology (CT). [1] Alternatively, lack of significant weight change may be reassuring to patients.

A patient’s perception of their weight change may not correlate with measured changes, or lack thereof, but that does not mean that clinicians should dismiss their perception. Most importantly, providers must listen to patients concerns, briefly review the medical evidence about weight change and use of contraceptive methods, and assist them in weighing the pros and cons of changing methods.

Progestin-only methods and weight changes

Injectables: Aside from unpredictable bleeding, weight gain is the most commonly reported side effect among DMPA users and is a commonly cited reason for discontinuation. Early clinical trials of DMPA relied on self-reported weight changes or discontinuation due to the same, which do not necessarily correlate with actual changes in weight with contraceptive use or differential changes among methods. [2]

In a 2016 review of clinical trials that measured weight changes in DMPA users, 15 studies noted no significant differences in mean weight gain or percentage change in body composition associated with DMPA use in comparison to other hormonal or nonhormonal methods write Lawley and Carrie Cwiak. Only three studies found a differential effect. Among them, two retrospective trials compared DMPA to copper intrauterine device (IUD) users: one study found that mean weight gain was higher for DMPA users at 1 year (mean difference 2.28 kg), 2 years (MD 2.71 kg), and 3 years of use (MD 3.17 kg), among normal weight and overweight, but not obese, users; the other study found that mean weight gain was higher for DMPA users at 1 year (1.3 vs 0.2 kg), 4 years (3.5 vs 1.9 kg), and 10 years of use (6.6 vs 4.9 kg).[2] Bonny et al. compared DMPA use to no hormonal contraceptive use in a small study of 26 adolescents and reported a significant increase in total body fat percentage (11%) and decrease in lean body mass percentage (–4%) at 6 months, though weight gain was not reported.[4] It should be noted that all but one of the 18 trials were considered very low to low in quality.[2] Given that DMPA is the only method that shows an association with weight gain and that weight gain is the most common reason people discontinue it, proactive and informative counseling about weight changes attributable to DMPA use and patient concerns is particularly relevant.

While the mean weight gain attributable to DMPA use may be of negligible or low magnitude for most users, some patients may be more likely to gain significant weight over time with DMPA use. One study of adult DMPA users suggests that a 5% weight change in the first 6 months of use was predictive of more progressive weight gain such that mean weight change was significantly higher (7.03 kg) by 36 months of use in those who experienced early weight gain. Other predictors included nonobese body mass index (BMI) and self-reported increase in appetite.[3] A study of adolescent DMPA users similarly found that DMPA users with a 5% weight change in the first 6 months had a higher mean BMI change (7.6 vs. 2.3) by 18 months of use compared to those who did not have an early weight change.[4] The high loss-to-follow-up rate in both studies limits the generalizability of these findings. Yet, it is reasonable to monitor weight and BMI changes over time in DMPA users to assist in counseling those who are concerned about weight gain.

IUDs: Although up to 10% of individuals will report concerns that their weight has increased after placement of an LNG IUD,[5] mean weight change at 1 year for LNG IUD users is 1 kg, which is less than seen with the use of subdermal or injectable contraception.[6]

Implants: Comparative trials have demonstrated that implant users did not have any differences in weight gain or body composition changes compared with copper IUD users.[7,8] The ability of postpartum users with BMI > 25 kg/m2 to lose weight by 6 months was also not statistically different from postpartum patients who used nonhormonal contraceptive methods.[9]

Progestin-only pills (POPs): A Cochrane review identified two comparative trials of POP effects on weight. One trial showed no significant weight change after 6 months of use of either a norethisterone or levonorgestrel POP. Another study of perimenopausal women that compared desogestrel POP to control showed no change in weight or body mass index after 12 months, with the desogestrel group showing a greater increase in fat mass.[10] No significant weight, heart rate, or blood pressure changes were observed with drospirenone POP in Phase III clinical trials.[11]

Combined hormonal contraceptive methods and weight changes

In clinical trials, women who use combined hormonal contraceptives (CHC)s do not typically gain more weight than they normally do in the same time interval without CHCs, write Shaalini Ramanadhan, MD, MCR, and Alison Edelman, MD, MPH, in the 22nd edition of Contraceptive Technology.[12] A Cochrane review confirmed that available evidence is insufficient to determine the effect of combination contraceptives on weight but concluded that no large effect was evident.[13] The hypothesized mechanisms for CHC-related weight gain include changes to the renin-angiotensin-aldosterone system causing fluid retention and hypertrophy of adipose tissue. But as no clear clinical evidence has been found, it is unlikely that any of these mechanisms cause significant problems.

COCs: Randomized clinical trials have demonstrated that, on average, patients do not experience more weight gain with low-dose COCs than with placebo or no intervention.[12,14,15] In a prospective trial of women using triphasic COCs with daily weight measurements for 4 months, no changes in mean weight fluctuations were noted during the cycle.[16] A 9-year study showed that COC use by adolescents was not associated with either weight gain or increased body fat.[17]

Rings: Rings have no significant impact on weight gain. In clinical studies, women are as likely to lose weight as to gain it when using the ring for a year.[18,19] A recent randomized review noted no large effect on weight among ring users, though the authors noted that available data were limited.[20]

Patches: Patches have no significant impact on weight gain. In a randomized placebo-controlled trial, the contraceptive patch was not associated with weight gain. In a pooled analysis of the clinical trials, the mean change in body weight from baseline to the end of treatment was an increase of 0.3 kg, and 79% of participants remained within 5% of their baseline weight.[21]

Acknowledgements: Additional CT authors whose work appears here are Melissa Chen, MD, MPH, and Melissa Matulich, MD, MAS (implants); Nicole Economou, MD, MPH, Biftu Mengesha, MD, MAS, and Eleanor Bimla Schwarz, MD, MS (IUDs); Charita Roque, MD, MPH, and Anne Burke MD, MPH (Progestin-only pills)


[1] Lawley M, Cwiak C. Injectable contraceptives. In: Cason P, Cwiak C, Edelman A, , et al. {Eds.] Contraceptive Technology, 22 nd Edition. Burlington, MA: Jones-Bartlett Learning, 2023.

[2] Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane
Database Syst Rev. 206;CD00815.
[3] Le RC, Rahman M, Berenson AB. A longitudinal comparison of body composition changes in adolescent
girls receiving hormonal contraception. J Adolesc Health. 2009;45:423-5..
[4] Bonny AE, Secic M, Cromer B. Early weight gain related to later weight gain in adolescents on depot
medroxyprogesterone acetate. Obstet Gynecol. 2011;117:793-7.
[5] Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy,
bleeding profiles, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems
and Mirena. Fertil Steril. 2012;97:616-22.
[6] Vickery Z, Madden T, Zhao Q, et al. Weight change at 12 months in users of three progestin-only
contraceptive methods. Contraception. 2013;88:503-8.
[7] Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF. Weight change at 12 months in
users of three progestin-only contraceptive methods. Contraception. 2013;88(4):503-8. DOI: 10
.1016/j.contraception.2013.03.004.
[8] Silva Dos Santos PN, Madden T, Omvig K, Peipert JF. Changes in body composition in women using
long-acting reversible contraception. Contraception. 2017;95(4):382-389. DOI:
10.1016/j.contraception.2016.12.006.
[9] Griffin L, Hammond C, Liu D, Rademaker AW, Kiley J. Postpartum weight loss in overweight and obese
women using the etonogestrel subdermal implant: a pilot study. Contraception. 2017;95(6):564-570. DOI:
10.1016/j.contraception.2017.02.020.
[10] Bonny AE, Secic DM, Cromer BA. A longitudinal comparison of body composition changes in
adolescent girls receiving hormonal contraception. J Adolesc Health. 2009;117:793-7.
[11] Palacios S, Colli E, Regidor P. Multicenter, Phase III trials on the contraceptive efficacy, tolerance, and
safety of a new drospirenone-only pill. Acta Obstet Gynecol Scand. 2019;98:1549-57.
[12] Ramanadhan S, Edelman A. Combined hormonal contraceptives. In: Cason P, Cwiak C, Edelman A, , et
al. [Eds.] Contraceptive Technology, 22 nd Edition. Burlington, MA: Jones-Bartlett Learning, 2023.
[13] Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane
Database Syst Rev. 2014 Jan 29 (1).
[14] Coney P, Washenik K, Langley RG, et al. Weight change and adverse event incidence with a low-dose
oral contraceptive: two randomized, placebo-controlled trials. Contraception. 2001;63:297-302.
[15] Goldzieher JW, Moses LE, Averkin E, et al. a placebo-controlled double-blind crossover investigation of
the side effects attributed to oral contraceptives. Fertil Steril. 1971;22:609-23.
[16] Rosenberg M. Weight change with oral contraceptive use and during the menstrual cycle. Results of
daily measurements. Contraception. 1998:58:345-9.
[17] Lloyd T, Lin HM, Mathews AE, et al. Oral contraceptive use by teenage women does not affect body
composition. Obstet Gynecol. 2002;100;235-9.
[18] Oddsson K, Leifels-Fischer B, de Melo NR, et al. Efficacy and safety of a contraceptive vaginal ring
(NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception.
2005;71:176-82.
[19] O’ConnellKJ,OsborneLM,WesthoffC.Measuredandreportedweightchangeforwomenusing a vaginal
contraceptive ring vs. a low-dose oral contraceptive. Contraception. 2005;72:323-7.
[20] Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives:
effects on weight. Cochrane Database Syst Rev. 2014 Jan 29;(1):CD003987.
[21] Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW. A comparative and pooled
analysis of the safety and tolerability of the contraceptive patch (Ortho EvraTM/EvraTM). Fertil Steril.
2002;77:19-26.

Other Latebreakers

Mar. 19, 2024

Weight Changes and hormonal contraceptives

Feb. 16, 2024

What most affects contraceptive continuation?

Jan. 03, 2024

Resuming CT monthly updates! Introducing the new edition of Contraceptive Technology

Dec. 20, 2021

Substance use disorder: contraceptive options counseling

Oct. 15, 2021

What’s New in Contraception?

Sep. 21, 2021

Contraceptive Technology Conference!

Aug. 25, 2021

Biologic sexism of STIs

Jul. 16, 2021

Excess breast cancer deaths after COVID-19

Jul. 04, 2021

Contraception for patients with medical conditions

May. 18, 2021

Pelvic Floor Dysfunction

Mar. 04, 2021

Treating vulvodynia

Feb. 11, 2021

Puzzling Over the Hurt Down-Under

Jan. 06, 2021

Serious Mental Illness and Contraception

Oct. 28, 2020

New 13-Cycle Vaginal Contraceptive System

Oct. 08, 2020

The Future of Family Planning in Post-COVID America

Sep. 09, 2020

New ASCCP Guidelines: Implications for FP

Aug. 02, 2020

On the alert: mood disorders during 2020 stressors

Jun. 25, 2020

Sex in the Time of COVID-19

May. 08, 2020

Challenges old and new during the pandemic

Mar. 31, 2020

Reproductive health in the time of Covid-19

Mar. 09, 2020

Talking about toys

Feb. 10, 2020

Missed Pills: The Problem That Hasn’t Gone Away

Jan. 02, 2020

Find the “yes! . . . and” rather than “no” or “but”

Nov. 01, 2019

Digital Family Planning: the Future is Now

Oct. 08, 2019

Irregular Bleeding Due to Contraceptives

Sep. 06, 2019

When she’s low on libido…

Aug. 06, 2019

Ouch! Best approaches to menstrual pain

Jun. 27, 2019

Contraceptive efficacy: understanding how user and method characteristics play their part

May. 29, 2019

Strategizing treatment for chronic heavy menstrual bleeding

May. 10, 2019

Perimenopause

Mar. 27, 2019

Untangling the literature on obesity and contraception

Feb. 26, 2019

High tech apps for no-tech FABM

Jan. 25, 2019

Menstrual exacerbation of other medical conditions

Jan. 04, 2019

From Princeton University: Thomas James Trussell (1949-2018)

Nov. 30, 2018

The Short and Long of IUD Use Duration

Oct. 30, 2018

Selecting a Method When Guidance Isn’t Clear-cut

Oct. 04, 2018

Healthcare in the Time of Digital Expansion

Aug. 30, 2018

Combined pills’ effect on mood disorders

Aug. 30, 2018

The Scoop on Two New FDA-Approved Contraceptive Methods

Aug. 01, 2018

Pregnancy of unknown location—meeting the challenge

Jul. 03, 2018

Big “yes” (with caveats) to CHCs during perimenopause

Apr. 02, 2018

Abortion in the U.S.: safe, declining, and under threat

Feb. 02, 2018

Hope for ovarian cancer screening test

Jan. 03, 2018

Breast cancer still a small risk with some hormonal contraceptives

Dec. 04, 2017

New treatment modality for BV

Nov. 07, 2017

Record rate of HPV-related throat cancer

Oct. 03, 2017

Viruses in semen potentially transmissible

Sep. 01, 2017

Don’t Abstain from Your Role in Abstinence

Jul. 26, 2017

Teens births declining but geographic ‘hotspots’ defy trend

Jun. 27, 2017

Online Medical Abortion Service Effective and Safe

May. 30, 2017

Do Women Really Need to Wait That Long?

May. 05, 2017

Reassuring news on depression and OC use

Apr. 06, 2017

PMDD: Genetic clues may lead to improved treatment

Mar. 02, 2017

Breast cancer risk when there is a family history

Feb. 03, 2017

Body weight link to breast and endometrial cancers (and 11 others)

Jan. 03, 2017

Family Planning in 2017 and Beyond

Dec. 01, 2016

Make Me Cry: Depression Link (Again)?

Nov. 02, 2016

Managing implant users’ bleeding and spotting

Oct. 13, 2016

Zika: Updated guidance for providers

Sep. 06, 2016

Pharmacist-prescribed contraceptives

Aug. 01, 2016

Hot off the press! 2016 MEC and SPR

Jul. 05, 2016

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Jun. 13, 2016

Opioid use epidemic among reproductive-age women

May. 04, 2016

Good news on the family planning home front!

Apr. 04, 2016

War Against Planned Parenthood Hurts Women

Feb. 16, 2016

Win-win for both treatment and prevention

Feb. 08, 2016

Center of the Storm

Dec. 01, 2015

Ambivalence

Nov. 02, 2015

Menopause, mood, mental acuity, and hormone therapy

Oct. 01, 2015

Emergency contraception for teens

Sep. 03, 2015

Postpartum Contraception: Now, Not Later

Aug. 03, 2015

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Jun. 25, 2015

Are we practicing what we preach?

Jun. 02, 2015

Be alert to VTE in hormonal contraceptive users

May. 04, 2015

LARC among teens increased 15-fold, but not enough

Mar. 30, 2015

Brain cancer and hormonal contraception

Mar. 02, 2015

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Feb. 02, 2015

Alcohol consumption when pregnancy is unwanted or unintended

Jan. 12, 2015

Latest Data on Contraceptive Use in the United States

Dec. 01, 2014

LateBreaker sampler from Contraceptive Technology conference

Nov. 05, 2014

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Sep. 29, 2014

Handout on Unintended Pregnancy and Contraceptive Choice

Aug. 27, 2014

Ask About Withdrawal (Really!)

Jul. 31, 2014

Rules to Practice By: Safety First and Cleanliness is Close to. . .

Jul. 01, 2014

What’s Vanity Fair Got Against the NuvaRing?

Jun. 02, 2014

Promising New Treatment for Hepatitis C

May. 01, 2014

Numbers matter, so make them simple for patients

Apr. 01, 2014

The Recession’s Effect on Unintended Pregnancies

Mar. 05, 2014

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Feb. 03, 2014

Applying the “New” Cervical Cytology Guidelines in Your Practice

Jan. 02, 2014

Acute Excessive Uterine Bleeding: New Management Strategies

Dec. 03, 2013

Medical indications for IUD use in teens

Oct. 09, 2013

Whatever happened to PID?

Oct. 05, 2013

Update on Emergency Contraception

Oct. 01, 2013

Contraceptivetechnology.com New and Improved